Automated Mucous Membrane Therapy Device with Sensor Feedback
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current metered-dose inhalers rely on patient activation and timing, which can lead to reduced effectiveness due to incorrect dosing and timing of medication delivery, potentially causing overdose or underdose, and are limited to respiratory diseases.
Innovation Solution
A medical device system that includes sensors to detect body signals, a detection unit to identify medical conditions, and a therapy device to administer medication directly to mucous or serous membranes, allowing for automated and precise delivery of therapy based on detected conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If a metered-dose inhaler is used to deliver medication, then the medication can be delivered to the lungs, but the patient must manually activate it which may lead to incorrect timing and dosage
Solution Approach 1:
The system enables self-service by using sensors to automatically detect patient conditions and trigger medication delivery without manual activation. The device monitors physiological parameters and autonomously determines when and how much medication to administer, eliminating the need for patient judgment while maintaining precise dosing.
Solution Approach 2:
The system implements feedback by continuously monitoring patient physiological signals through sensors and using this information to adjust medication delivery timing and dosage. The closed-loop control ensures that medication is administered based on actual patient needs rather than manual patient initiation, improving dosing precision.
2Reliability
If the patient determines timing and dosage manually, then the patient can control the treatment, but errors in dosage and timing may occur leading to overdose or underdose
Solution Approach 1:
The system replaces manual patient judgment and mechanical activation with automated sensor-based detection and electronic control. Physiological sensors monitor patient status and an electronic delivery mechanism administers medication automatically, eliminating human error in timing and dosage determination while improving treatment reliability.
Solution Approach 2:
The system introduces an intermediary detection unit that acts as a mediator between the patient's physiological state and the medication delivery mechanism. This intermediary processes sensor data and translates it into appropriate dosing decisions, removing the need for direct patient control while ensuring reliable and accurate treatment administration.
3Adaptability or versatility
If metered-dose inhalers are used, then respiratory diseases can be treated, but the application is limited only to respiratory diseases
Solution Approach 1:
The system achieves universality by designing a platform that can deliver multiple types of medications through a single integrated device. The automated delivery system is not limited to respiratory medications but can administer various drug types for different conditions including neurological disorders, making the device multi-functional and adaptable to diverse medical needs.
Data Source
AI summary
A method, apparatus, and system are provided for mucous membrane therapy. The method includes receiving at least one body signal from a patient; detecting a condition of the patient based on the body signal; and administering the therapy to at least one of a mucous membrane or a serous membrane of the patient. A medical device system configured to implement the method is provided. A computer-readable storage device for storing instructions that, when executed by a processor, perform the method is also provided.